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Abstract
Background: Given the complexity of higher organisms, the number of genes encoded by their
genomes is surprisingly small. Tissue specific regulation of expression and splicing are major factors
enhancing the number of the encoded products. Commonly these mechanisms are intragenic and
affect only one gene.
Results: Here we provide evidence that the IL4I1 gene is specifically transcribed from the apparent
promoter of the upstream NUP62 gene, and that the first two exons of NUP62 are also contained
in the novel IL4I1_2 variant. While expression of IL4I1 driven from its previously described
promoter is found mostly in B cells, the expression driven by the NUP62 promoter is restricted to
cells in testis (Sertoli cells) and in the brain (e.g., Purkinje cells). Since NUP62 is itself ubiquitously
expressed, the IL4I1_2 variant likely derives from cell type specific alternative pre-mRNA
processing.
Conclusion: Comparative genomics suggest that the promoter upstream of the NUP62 gene
originally belonged to the IL4I1 gene and was later acquired by NUP62 via insertion of a retroposon.
Since both genes are apparently essential, the promoter had to serve two genes afterwards.
Expression of the IL4I1 gene from the "NUP62" promoter and the tissue specific involvement of the
pre-mRNA processing machinery to regulate expression of two unrelated proteins indicate a novel
mechanism of gene regulation.
Background
Many mechanisms for the alternative use of promoters,
exons and polyadenylation signals within genes are
known to significantly contribute to the complexity of the
transcriptome [1-6]. These variations increase the number
of products that can be generated from the currently rec-
ognized 20,000 – 30,000 protein-coding genes of the
human genome [7]. For example, alternative promoters
are used to confer specificity of mRNA expression in time
and space [8,9] and of mRNA translation [10]. Often the
N-terminal ends of proteins are altered to generate or
remove signal sequences for protein localization [11].
Central exons may or may not be present thus changing
the peptide sequence and properties [12]. The alternative
use of polyA signals also has effects, for instance, on RNA
stability [13,14].
The mechanisms described above all have in common the
fact that the elements involved are associated only with
the gene being transcribed and not with any other gene.
The mechanism of trans-splicing, in which elements from
more than one gene are involved in the generation of
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appears to be rare and its function is still not well under-
stood [15]. Overlapping genes and transcripts have been
described in many species and occur in several varieties
[16-18]. However, in vertebrates, few transcripts have
been described which join two genes with different read-
ing frames [19]. We have found evidence for sequence
overlap of transcripts from two protein coding genes,
NUP62 and IL4I1, where the latter is expressed in a tissue
and cell-type specific manner. Both genes are transcribed
from the same promoter and share the first two exons. A
similar process has been described for Caenorhabditis ele-
gans [20], in which mRNAs of two cholinergic proteins are
transcribed from one promoter. Until now, this principle
did not appear to be conserved in higher eukaryotes. The
NUP62/IL4I1 genes are therefore the first proof that this
mechanism is present in vertebrates. However, in contrast
to what has been observed in C. elegans, the functions of
the two proteins encoded by the one promoter are com-
pletely unrelated.
The protein encoded by NUP62 belongs to the class of
nucleoporins (Nups) and is an essential part of the
nuclear pore complex [21,22]. Its N terminus is believed
to be involved in nucleocytoplasmic transport, while the
C-terminal end contains a coiled-coil structure aiding in
protein-protein interactions, and may function in anchor-
age of the protein in the pore complex (Annotation for
P37198 in Swiss-Prot [23]). Nup62, like the other Nups,
is conserved in the eukaryote kingdom [24,25]. The
NUP62 gene consists of a single promoter with a CpG
island and three transcribed exons. The protein is encoded
exclusively by the terminal exon; the first two exons are
non-coding. The second exon is prone to alternative splic-
ing and is not contained in about half of the reported
cDNAs derived from that gene (e.g., IMAGE:3050260 [26]
and DKFZp547L134 [27]). NUP62 is ubiquitously
expressed, an observation compatible with its essential
role in transporting cargo across the nuclear envelope.
IL4I1 was initially identified to be exclusively expressed in
B lymphoblasts as a gene that was induced by treatment
with interleukin 4 (IL-4) [28,29]. Since then, the encoded
protein has been identified as a leukocyte specific L-
amino acid oxidase (LAAO; [30]) that specifically oxidizes
aromatic amino acids. The protein contains an N-terminal
signal peptide, which targets the protein to the endoplas-
mic reticulum and presumably to the lysosomes [30],
where it is believed to be involved in antigen processing
in B cells [30] and thus act in the immune response. The
gene is reported to be transcribed from a single promoter,
which appears to restrict expression to cells of the
immune system, mostly in B lymphocytes [31]. It consists
of eight exons, and the translation start is located in the
second exon. The gene is conserved in eutherian mam-
mals (NCBI HomoloGene:22567), but has not been iden-
tified in other eukaryotes and in prokaryotes.
We have identified several expressed sequence tags (ESTs)
that indicate expression of IL4I1 in tissues other than B
lymphocytes, namely human and mouse testis and brain.
This expression of the IL4I1 gene was apparently driven by
the same promoter as the upstream NUP62 gene. We have
verified expression of the Il4i1_2 variant in mouse testis
and brain, and thus show that the previously reported
NUP62 promoter also drives expression of a second gene
in a cell-type and tissue specific manner. The mRNA con-
sists of sequence from both genes and two joining exons
which are not part of either previously reported gene
locus. Our findings indicate a new mechanism of gene
regulation in which two genes that encode unrelated pro-
teins share the same promoter but yet are still expressed in
radically different cellular patterns. This suggests that the
nature of the transcripts and proteins encoded by these
two genes is controlled by tissue specific regulation of pre-
mRNA processing.
Results
The exon structure of variant IL4I1_2 joins the described 
NUP62 and IL4I1 genes
Based on the available sequence information we predicted
the gene structure for the human variant IL4I1_2 tran-
script represented by cDNA IMAGE: 5742307 in Fig. 1. To
validate this structure we obtained several Mammalian
Gene Collection clones that cover the splice variant and
sequenced them to completion. One cDNA
(IMAGE:4822638; Acc: BC026103) contained two muta-
tions leading to premature in-frame stop codons. A sec-
ond cDNA (IMAGE:5168029) contained exon 2 (35
nucleotides) of the previously reported IL4I1 gene [32],
also disrupting the open reading frame (ORF). The
remaining clones (IMAGE:5171014, IMAGE:5742307
and IMAGE:4838597) matched the predicted gene struc-
ture and thus supported the sequence of the variant. This
gene structure includes the presumed first two exons of
the NUP62 gene which are both part of the 5' untranslated
region (UTR). Transcription of that variant is apparently
controlled by the promoter that also controls expression
of the NUP62 mRNA.
The terminal and coding exon from the NUP62 gene is not
contained in the IL4I1_2 variant (Fig. 1). While the initia-
tor ATG of the reported IL4I1 ORF is located in exon 2, the
first two exons of the known IL4I1 gene are absent in the
variant. Instead, the variant contains two additional exons
(indicated with red arrowheads in Fig. 1) that are located
in the region between the previously reported NUP62 and
IL4I1 loci. The latter of the two exons contains the
assumed translation initiator ATG.Page 2 of 12
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The splice variant is conserved in other eutherian mam-
mals where order and orientation of the NUP62 and IL4I1
genes are syntenic. Five ESTs from mouse verify the tran-
scription and splicing of the Il4i1_2 variant. Like the
human ESTs, the mouse ESTs were derived from cDNAs
that had been generated from either testis or pooled tis-
sues. One EST was sequenced from rat testis. All these
cDNAs contain the first exon of the Nup62 gene, two inter-
genic exons and then exon 3 of the Il4i1 gene. There is
apparently no homolog of human exon 2 of NUP62 in
mouse and rat. Mouse Nup62 is thus the equivalent of the
human splice variant represented by cDNA
DKFZp547L134. The location and sequences of the join-
ing exons that are specific for the IL4I1_2 variant are con-
served between mouse, dog and human. Sequence
conservation of the variant joining exons is higher than
that of exons 1 and 2 of previously reported IL4I1 (Fig. 2).
The probable translation initiation codon in exon 4 (exon
3 in mouse and rat) lies within a consensus Kozak
sequence context (Fig. 2; [33]). An upstream ATG, which
is in frame with the ATG we propose to initiate transla-
tion, does not match the Kozak consensus rules. It is
present in human and chimpanzee, but not in mouse, rat
or dog, and thus is not convincing; we suspect it could be
prone to leaky scanning [33]. We conclude that transla-
tion either starts at the conserved ATG, or that use of the
upstream ATG could possibly change some property of
Structure of the human NUP62 and IL4I1 genes at chromosomal band 19q13Figure 1
Structure of the human NUP62 and IL4I1 genes at chromosomal band 19q13.33. Genes are both shown from 5' 
(left) to 3' (right). Exons are represented by vertical bars and boxes, intronic sequence by horizontal lines. The NUP62 gene 
(three exons) is located upstream and tail-to-head to the previously reported IL4I1 gene (eight exons). NUP62 has two splice 
variants represented by cDNAs IMAGE:3050260 (includes exon 2), and DKFZp547L134 (skipped exon 2). The Nup62 protein 
is encoded by exon 3 (blue box). IL4I1 does not have reported splice variants and is represented by the sequence AF293462. 
Translation start of the protein is located in exon 2 (blue bars represent coding region). Several cDNAs were identified to link 
NUP62 and IL4I1 transcripts (representative: IMAGE:5742307). The splice form consists of the first two apparent exons of the 
NUP62 gene, two joining exons mapping in between the reported NUP62 and IL4I1 gene loci (red arrow heads), and exons 3–
8 of the known IL4I1 gene. Translation start of the protein is in the second joining exon. The sequences of the joining exons 
are conserved in eutherian species, but not for instance in chicken or fish (taken from UCSC genome browser [54]). The 
reported promoter of the NUP62 gene contains a CpG island, while the promoter of previously known IL4I1 does not. The 
two genes cover 40 kb on the chromosome.Page 3 of 12
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tein is predicted (SignalP [34]) to be a signal peptide (P =
0.969) when starting at the Kozak-ATG, the extended N
terminus is predicted to be a signal anchor (P = 0.587)
and not a signal peptide (P = 0.316). An extension at the
N terminus might thus change localization of the protein.
All transcripts analyzed had a short six (dog: seven) resi-
due upstream ORF, the localization and sequence of
which was conserved. It remains to be determined
whether this ORF is expressed in vivo as has been shown
for other genes [35]. This ORF is too small and too close
to the initiator ATG of the IL4I1-ORF to suggest an inter-
nal ribosome entry site (IRES) – type mechanism [36].
The IL4I1 gene has thus far only been found in eutherian
mammals. This is supported by analysis of the genes
downstream of the NUP62 orthologous genes in non-
eutherian species. In Fugu rubripes, the next gene down-
stream of NUP62 is a homolog of human integrin alpha
6, and the two genes are oriented tail to tail. In Gallus gal-
lus, the next gene downstream is the homolog of a human
X-chromosomal gene (FLJ11016) with unknown func-
tion, and the genes are oriented head to tail. In Drosophila
melanogaster, Nup62 is followed by a hypothetical WD-
repeat protein (CG7989), which is in the opposite orien-
tation (tail to tail) to Nup62. The situation in the opossum
(Monodelphis domestica; thus far the only marsupial species
sequenced) is unclear, as the sequence scaffold that covers
NUP62 terminates 4 kb downstream and no gene is anno-
tated there. However, the two genes that, according to
annotation, flank opossum NUP62 do not map to the
chromosomal region that harbors human NUP62 and
IL4I1. In addition, no ortholog of the IL4I1 gene has yet
been identified in the opossum genome. Thus, the evi-
dence so far suggests that expression of variant IL4I1_2
(just as of original IL4I1) might be restricted to eutherian
mammals. The sequencing and transcript analysis of more
mammalian species will help to uncover the origin of the
IL4I1 gene and its variant.
Mature ll4i1 protein and its variant are likely identical in 
sequence
Since the translation start in the previously reported IL4I1
transcript differs from that in the variant described here,
the two protein products differ at their N termini. Fig. 3
shows a sequence alignment of the N-terminal ends of
Il4I1 and the new variant. The N termini of Il4i1 and
those of the variant Il4i1_2 are conserved in the species
analyzed. The Il4i1 protein has been reported to be trans-
ported into the endoplasmic reticulum and the endo-
somes with help of an N-terminal signal peptide [30].
Alignment of sequences upstream the IL4I1 and variant IL4I1_2 open reading framesFigure 2
Alignment of sequences upstream the IL4I1 and variant IL4I1_2 open reading frames. Alignments of IL4I1 (upper 
panel) and variant IL4I1_2 (lower panel) sequences are shown. The first two exons of IL4I1 are shown, and splice sites are 
underlined and in bold. Ten nucleotides of the next intron are displayed downstream of the first coding exon, which all match 
the consensus splice donor sequence. Reading frames are in all caps, and the deduced peptide sequences are given below. The 
human and chimpanzee sequences of IL4I1_2 have an upstream and in-frame start codon (bold), which is not conserved in 
mouse, rat or dog, and which does not match the Kozak consensus rules. All IL4I1_2 sequences have a short upstream ORF 
(all caps) which is conserved in location and sequence. The mouse, rat and human sequences were derived from cDNA 
sequences, while the chimpanzee and dog sequences were deduced from an alignment of human cDNA with the respective 
genome sequences [54].Page 4 of 12
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upstream of the glutamine residue at position 22 of the
human variant protein. The homologous position is a leu-
cine in the mouse protein and is there predicted to be the
cleavage site. The same residue is the cleavage site also in
the previously reported Il4i1. Consequently the processed
proteins are probably identical in sequence, and only dif-
fer in the length of the respective signal sequences. We
next analyzed whether the N terminus of the Il4i1_2 vari-
ant may serve as signal peptide in vitro and expressed the
protein in fusion with green fluorescent protein (GFP) in
mammalian cell culture [37,38]. The variant protein was
indeed translocated into the endoplasmic reticulum [39]
when overexpressed, and had the same localization as an
overexpressed Il4I1-GFP fusion protein (not shown).
The IL4I1_2 variant is specifically expressed in testis and 
brain
EST evidence indicated that expression of the variant tran-
script might be tissue specific, as cDNAs exclusively from
testis and brain had been sequenced. We analyzed the
expression of the variant transcript in Northern blots of
fetal and adult mouse (Fig. 4). A probe specific for the var-
iant IL4I1_2 was employed, comprising the two joining
exons downstream of the NUP62 coding exon. These
exons are indicated with red triangles in Fig. 1. No expres-
sion of the Il4i1_2 variant was observed in fetal mice and
in most adult tissues. A strong and specific band at 2.45 kb
was only observed in the testis. The variant Il4i1_2 tran-
script is predicted to be 2.3 kb in size, not counting the
polyA tail, when sequence of the ESTs (Methods) is
extended with the known Il4i1 sequence towards its 3'
end. The human variant IL4I1_2 is of similar size. Expres-
sion in the brain was expected because of cDNAs and ESTs
available from that tissue, but not observed in Northern
blot analysis. A smaller RNA of unknown sequence at 1.8
kb was visible in the fetal mouse, and in adult mouse liver,
kidney and testis.
Having identified expression of the Il4i1_2 variant in a tis-
sue other than B lymphocytes, we next carried out RNA in
situ hybridization to identify a possible cell-type specifi-
city of this expression, and to find other tissues and cells
where the variant is expressed. Expression of variant
Il4i1_2 was found in testis to be predominantly in Sertoli
cells at the periphery of the ducts (blue spots in Fig. 5,
panels A1 and A2). In contrast to the Northern analysis,
where brain did not have detectable expression of the
Il4i1_2 variant, RNA in situ hybridization revealed expres-
sion of the variant transcript in the adult mouse brain
(Fig. 6). Purkinje cells (cerebellum), cells of the hippoc-
ampus, and mitral cells in the olfactory bulb were specifi-
cally stained with the Il4i1_2 specific antisense probe (Fig.
6). Even though expression in some cell types within the
brain was strong, overall expression of variant Il4i1_2 in
the brain was weak, matching the results obtained with
pooled brain tissue in the Northern analysis. No signals
were detected in adult liver and kidney or in any of the
embryonic stages by RNA in situ hybridization (not
shown).
Sequence alignment of N-terminal ends of peptides encoded by the IL4I1 gene (Il4i1) and the novel variant (Il4i1_2)Fig re 3
Sequence alignment of N-terminal ends of peptides encoded by the IL4I1 gene (Il4i1) and the novel variant 
(Il4i1_2). Sequences encoded by the first coding exon are different between the two variants, and the splice site is indicated 
with a red arrowhead. The mouse sequence of Il4I1_2 was derived from the following ESTs: BY100275, BY099330, BY087056, 
BY092834 and BY088421. The rat sequence was translated from the EST CV117152. Dog and chimpanzee sequences were 
deduced from aligned genomic sequences [54]. The cleavage site of the signal peptidase is predicted at the same position in all 
sequences and is indicated with a blue arrow head.Page 5 of 12
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We here report a novel transcript variant of the IL4I1 gene,
which is a product of two exons from the previously
described NUP62 gene, two apparently joining exons
mapping between the reported NUP62 and IL4I1 gene
loci, and six exons of the known IL4I1 gene. Expression of
that variant is driven by the assumed NUP62 gene pro-
moter with high tissue and cell type specificity. The pro-
tein encoded by the variant IL4I1_2 transcript is
essentially the same as that of the originally described
Il4i1 protein [32], since the primary structures of the
encoded proteins are identical after probable cleavage of
the predicted signal peptides. Although a different func-
tionality of the variant signal peptides cannot be excluded
[40], the expression of this otherwise B-cell specific gene
in testis and brain already adds significantly to the previ-
ously known properties of that gene and the encoded
enzyme. The tissue specificity of the reported IL4I1 pro-
moter [31] appears to be essential for survival, and expres-
sion of that gene appears to be tightly controlled. Given
the function of the encoded protein, a LAAO enzyme,
such restriction of protein expression makes sense. Limit-
ing IL4I1 expression to B cells would take reference to the
specific function of that cell type (e.g. antigen processing).
In contrast, the Il4i1 protein is likely not involved in the
immune system/antigen processing when expressed in
testis or the brain. While the function of that protein in
these tissues thus remains to be established, a possible
involvement in disease should be analyzed. The lysyl oxi-
dase (LOX) has been found at elevated levels in amyo-
trophic lateral sclerosis (ALS) and in superoxide
dismutase (mSOD1) knockout mice (which exhibit an
ALS-like syndrome) and is believed to be involved in the
progression of ALS [41]. The LAAO activity of Il4i1 makes
this protein a new candidate not only for ALS, but also for
other diseases associated with the death of Purkinje cells
[42]. For example, the chromosomal location of the IL4I1
gene at 19q13.31 has been described as candidate region
for spinocerebellar ataxia type SCA19. Elevated expression
levels of IL4I1 have also been reported in primary medias-
tinal large B-cell lymphoma [43], thus associating this
gene with cancer as well. Further experimentation will be
necessary to establish a possible role of the variant IL4I1_2
in any of these or other diseases.
The previously described IL4I1 promoter appears to be
strictly specific for B-cell expression. It does not contain a
CpG island and is reported to be induced for instance by
STAT6 [31]. In contrast, the IL4I1_2 variant in the human
Northern hybridization with probe specific for the mouse Il4i1_2 splice var anFigur  4
Northern hybridization with probe specific for the 
mouse Il4i1_2 splice variant. Blots contained poly A+ 
RNA from fetal mice 7 dpc (1), 11 dpc (2), 15 dpc (3), 17 dpc 
(4) and adult mouse tissues (heart (5), brain (6), spleen (7), 
lung (8), liver (9), skeletal muscle (10), kidney (11), and testis 
(12). Hybridization was with a probe comprising the joining 
exons 2 and 3 of the mouse Il4i1_2 variant, which are equiva-
lent to human exons 3 and 4 (red arrowheads in Fig. 1). The 
blots were reprobed for beta actin mRNA as control for 
RNA content. The probe cross-hybridized with gamma actin 
mRNA where expressed.
RNA in situ hybridization of variant Il4i1_2 in mouse testisFigure 5
RNA in situ hybridization of variant Il4i1_2 in mouse 
testis. Probes were transcribed from the joining exons spe-
cific for variant Il4i1_2, which are located between the previ-
ously known Nup62 and Il4i1 gene loci. Signals (in blue) 
obtained with the antisense probe are on the left (A), and 
those obtained with sense probe are on the right (B). The 
scale bar is 100 µm in 1A and B, 50 µm in 2A and B.Page 6 of 12
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RNA in situ hybridization of variant Il4i1_2 in different areas of adult mouse brain. Shown are sagittal sections from 
cerebellum (1), cortex (2), hippocampus (3) and olfactory bulb (4). Probes were transcribed from the joining exons specific for 
variant Il4i1_2, located between the previously known Nup62 and Il4i1 gene loci. Signals (in blue) obtained with the antisense 
probe are on the left (A), and those obtained with the sense probe are on the right (B). The scale bar is 500 µm in 2A and 3A, 
and 200 µm in the other images.Page 7 of 12
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NUP62 gene has a CpG island and is ubiquitously
expressed. In consequence, pre-mRNAs are spliced to
produce the novel variant only in testis and brain. How-
ever Purkinje and Sertoli cells also require functional
nuclear pore complexes to survive. Correct amounts of
both mRNAs need to be generated within the cells. The
amounts could be regulated most likely at the splicing
and/or polyadenylation levels, or by specific mRNA deg-
radation. In consequence, the variant IL4I1_2 transcript is
indicative of a so far undetected mechanism of gene regu-
lation. While the presence of alternative promoters is a
common theme in many genes, the cell-type specific
expression of two genes from one promoter is novel, espe-
cially when the transcripts contain exons from both genes.
Thus far, gene fusions had mostly been associated with
disease [44]; for example, trans-splicing is associated with
viral infection [45]. However, the process reported here
occurs in normal individuals and could be essential in the
expressing cell types. Apparent joining of genes as indi-
cated by cDNA sequences takes place at a rather high rate,
but in many cases these cDNAs are likely to have been the
result of errors in the pre-mRNA processing machinery
[46]. One example is AK074097, which points to a fusion
between IL4I1 and the downstream gene encoding TBC1
domain family member 17. However, these genes are ori-
ented tail to tail, and the sequence structure of AK074097
is not supported by any further cDNA data. AK074097
even extends into the next further downstream gene
AKT1S1. The "splice variant" represented by this cDNA
therefore most likely originated from the lack of transcrip-
tional termination and mis-splicing of cryptic "exons".
This cDNA could thus be regarded as biological noise
[46]. While being probably not of functional relevance,
this and many other similar cDNA sequences (also
IMAGE:5168029) raise questions as to the fidelity of RNA
production and processing in cells, and as to the require-
ment of biological systems to be able to tolerate such
events. Since errors at the RNA level are not inherited per
se, the observed phenomena presumably are indicative of
the flexibility and stability of the cellular system, rather
than that these RNAs themselves would contribute to the
evolutionary principle directly. Our findings now suggest
that promiscuity of the pre-mRNA processing machinery
is a required mechanism on a higher than previously
reported [5,6,47,48], i.e., a trans-gene level, and that it is
regulated at tissue and cell-type levels.
Several questions remain unanswered. Why and how is
the pre-mRNA spliced to specifically produce the variant
IL4I1_2 mRNA? Is transcription of RNA polymerase past
the 3'-terminal exon of NUP62, which is required to join
exons from the apparent NUP62 and IL4I1 genes,
restricted to the cell types and tissues where the variant is
detected, or is the tissue specificity of that variant mRNA
determined in the splicing/polyadenylation process? Why
is IL4I1 expression driven by the NUP62 promoter at all?
More globally, is this a unique mechanism or are there
more genes that are driven by the promoters of upstream
genes? Are there other cases where an apparently leaky
splicing mechanism could be favourable over the risk of
erroneous transcription from a more promiscuous pro-
moter? And finally, how did this mechanism evolve? The
evolution of this mechanism would have required at least
three events to happen, probably in early eutherian devel-
opment: 1) the installation of neighborhood and orienta-
tion of these two genes, 2) the continuation of
transcription beyond the NUP62 translated exon and its
transcription termination signals, and 3) the development
of tissue specificity for NUP62 and IL4I1_2 pre-mRNA
processing. Selective pressure appears to have favoured
preservation of the status quo. Sequence conservation of
those exons that are specific for the variant is even higher
than that of exons 1 and 2 of the previously reported IL4I1
transcript. This could hint to an essential function of the
variant and to the possibility that it was not IL4I1 that
integrated downstream of NUP62, but that instead
NUP62 integrated into the IL4I1 gene. The latter hypoth-
esis is supported by the fact that the complete NUP62 ORF
is located on one exon in mammals, while it is split into
several exons in other eukaryotes. Thus the so-called
NUP62 promoter might actually be an ancient IL4I1 pro-
moter that triggered expression of two independent ORFs
after integration of a NUP62 retroposon. An immediate
question would follow: what happened to the original
NUP62 gene in eutherians? The cDNA FLJ20130, which
maps to human chromosome Xq22.3 encodes a protein
that is homologous to part of Nup62, namely the most
conserved nucleoporin Nsp1-like C-terminal domain
(IPR007758). That domain is fundamental for interaction
with Nup82, another protein of the nuclear pore complex.
The exon/intron structure of at least three exons in the
FLJ20130 locus is the same as in the chicken NUP62 gene
(Fig. 7A). The conservation of FLJ20130 and NUP62
extends into the 3'UTR of FLJ20130, which is however
part of the coding region of NUP62 (Fig. 7A). In human,
dog, mouse and opossum, the FLJ20130 gene is flanked
by CXorf 41 (upstream) and FLJ11016 (downstream) and
their orthologs, respectively. The same homologous genes
flank the NUP62 gene in chicken in identical order and
orientation. FLJ20130 in human Xq22.3 might conse-
quently be a remnant of the ancient NUP62 in mammals,
having lost a number of exons and much of its coding
region. Other examples of retrogenes have been reported
[49]. In contrast to the ubiquitous expression of NUP62,
EST data from mouse and human suggest that expression
of FLJ20130 is mostly in early development. These find-
ings indicate this probable ancient form of mammalian
NUP62 may still be expressed but is likely to havePage 8 of 12
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Alignment of NUP62 and FLJ20130. (A) Protein sequences of human, opossum and chicken Nup62 were aligned with the 
peptide encoded by cDNA FLJ20130. While most of the mammalian NUP62 genes do not contain introns, the chicken NUP62 
gene and the human gene encoding FLJ20130 do. Exon boundaries in the latter two sequences are indicated with pipes (|), and 
the lack of introns is indicated at the respective positions by dashes (-). The positions of exon boundaries are additionally high-
lighted in yellow. The N terminus of chicken Nup62 is probably incomplete. (B) Dot-plot of human nucleotide sequences 
FLJ20130 (presumed ancestor of NUP62) and AL162061 (NUP62). Windowsize was 55 bp, and stringency was set to 60% 
sequence identity. Coding regions in the two cDNAs are indicated with blue bars, and ORF boundaries are linked to the dot-
plot alignment. The alignment extends past the protein coding sequences. The terminal and coding exon of AL162061 starts at 
position bp 129 and comprises the assumed retroposon.Page 9 of 12
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region, however, could implicate this protein to be
involved in the nuclear pore complex as well.
The mechanism that determines the processing of NUP62/
IL4I1_2 pre-mRNAs into its final form also remains to be
identified. An attractive model would be the frequently
observed use of alternative polyadenylation sites that is
coupled to alternative splicing [50]. Then the terminal
exon of NUP62 could be interpreted as "merely" an
alternative 3'-end of the IL4I1 gene, or the downstream
exons of IL4I1 were alternative ends of the NUP62 gene. A
possible NUP62 retroposon would have contained a
polyadenylation signal and a polyA-tail. Consensus poly-
adenylation signals (AAUAAA) are present in the NUP62
gene and transcripts while the polyA tail appears to have
vanished since the time of integration. The downstream
sequence element needed to make the polyadenylation
signal functional [51] and to terminate transcription must
have been present within the intron of the IL4I1 gene into
which the retroposon inserted.
Conclusion
We have identified and verified a novel mechanism for
regulation of gene expression that involves the transcrip-
tion of two genes from the same promoter and the
processing of two variant mRNAs from probably the same
pre-mRNA. The encoded proteins are completely unre-
lated. Conservation of this mechanism in eutherians sug-
gests both transcripts and the encoded proteins are
essential for survival. Finally, our finding puts the current
definition of the term "gene" in question, as the variants
we have identified and analyzed are clearly the product of
two genes. In addition to one promoter driving the expres-
sion of these genes, two of the formerly named NUP62
exons are also part of the IL4I1_2 variant. Should these
exons be counted as belonging to the NUP62 or to the
IL4I1 genes? One current definition of a gene is "a com-
plete chromosomal segment responsible making a func-
tional product" [52]. The chromosomal segment
encoding the B-cell variant of IL4I1 appears completely
separate from that of NUP62 and thus fulfils all criteria of
the above definition. This is not true however for the
newly detected IL4I1_2 variant. NUP62 and IL4I1_2 share
noncoding regulatory DNA sequences, exons and introns
within one chromosomal segment. The functional
sequences of NUP62 and IL4I1_2, however, are unique
and distinct, which is another criterion used to separate
two genes. In consequence, the above definition of a
"gene" should be put in question. Nature may have more
surprises to reveal, and with increasing amounts of data
on genomes, transcriptomes and proteomes being
collected and analyzed, other paradigms may require
revision.
Methods
Identification of splice variant
The cDNA IMAGE:4822638 (Acc:BC026103) was cloned
and sequenced by the Mammalian Gene Collection [26].
More cDNAs were identified in the University of Califor-
nia, Santa Cruz (UCSC) genome browser [53,54] (assem-
bly of May 2004), based on their EST sequences to cover
part of the IL4I1_2 variant (IMAGE:5168029,
IMAGE:5171014, IMAGE: 5742307, IMAGE:4838597).
All these cDNAs were obtained from The German
Resource Centre for Genome Research (RZPD; [55]) and
completely sequenced with help of walking primers [56].
Sequences were assembled and aligned using the Staden
package [57] to identify base substitutions and other alter-
ations from the predicted consensus sequence.
Comparative genomic analysis
Comparative genomic analysis of the IL4I1_2 variant was
done with help of the UCSC genome browser [53], which
indicated variant cDNAs from mouse [58] (ESTs
Acc:BY100275, BY099330, BY087056, BY092834,
BY088421) and rat (Acc:CV117152). Alignment of pro-
tein sequences was done with Vector NTI software (Invit-
rogen). Synteny of genomic regions downstream of the
NUP62 orthologs was analyzed in the genome assemblies
and datasets of human (hg17), chimpanzee (panTro1),
dog (canFam1), mouse (mm5), rat (rn3), opossum
(monDom1), chicken (galGal2), Fugu (fr1), and Dro-
sophila (dm1), all in the UCSC genome browser [54].
Northern hybridization
Multiple tissue Northern blots with poly-(A)+-RNA from
mouse embryonic (Cat.# 636810) and mouse adult tis-
sues (Cat.# 636808) were obtained from BD Biosciences
Clontech. A probe specific for the mouse variant Il4i1_2
transcript was generated with the primers mmNupIlR1
(GAAGAACACAGGCAGATGCCCTG) and mmNupIlS1
(TGCATGGTGGTCTTTGTGGGGC), which were used to
amplify the mouse joining exons 2 and 3 of the variant
Il4i1_2 (equivalent to the human exons 3 and 4 indicated
with red arrowheads in Fig. 1) from mouse testis RNA via
RT-PCR. The 208 bp PCR product was cloned into the
pCRII vector (Invitrogen), and sequence verified. Filters
were hybridized with 32P-labelled purified PCR products
from that clone. Hybridization was overnight in Church
solution (1M Na2HPO4, 1M NaH2PO4·H2O, 10mM
EDTA, pH8.0) at 65°C. Filters were washed once in 0.1%
SDS/0.1xSSC for 10 min, once in 0.1% SDS/0.3xSSC for
10 min, and then exposed to Kodak Bio Max at -80°C.
RNA in situ hybridization
RNA in situ hybridization was performed on embryo sec-
tions at stages 10.5, 12.5, 14.5, 16.5 and different tissues
of adult mice (testis, kidney, liver and brain). Embryos
were isolated from pregnant NMRI mice. The day of plugPage 10 of 12
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(dpc). The tissues and embryonic stages were fixed over
night in 4% paraformaldehyde (PFA) in phosphate-buff-
ered saline (PBS) at 4°C. The tissues from adult NMRI
mice were isolated after perfundation with 4% PFA in
PBS. After embedding in paraffin, 6 µm sagittal sections
were mounted on Superfrost+ slides. Cloned PCR prod-
ucts (see Northern hybridization) were sequence verified
to identify orientation of the product within the vector.
Antisense (T7) and sense (SP6) riboprobes labeled with
digoxigenin-UTP (Enzo) were generated by in vitro tran-
scription (Roche), after linearization of the constructs.
Pre-treatment, hybridization and washing were carried
out using a Ventana discovery system. Sense or antisense
RNA probes were hybridized at 100ng RNA/ml in hybrid-
ization buffer in a volume of 100 µl/slide. Slides were ana-
lyzed using a Leica microscope.
Photographs were taken with a liquid crystal display
(LCD) – camera (Power head, Sony) using AnalySIS soft-
ware (Soft imaging System GmbH). The figures were
assembled using Adobe Photoshop.
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